Cholestasis enhances liver ischemia/reperfusion-induced coagulation activation in rats

Hepatology Research

Volumn 40, Issue 2, 2010, Pages 204-215

  Kloek, Jaap J ^a   Levi, Marcel ^a   Heger, Michal ^a   van der Loos, Chris M ^a   Gouma, Dirk J ^a   van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cholestasis; Coagulation; Fibrinolysis; Ischemia reperfusion damage; Liver; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; BLOOD CLOTTING; CHOLESTASIS; CONTROLLED STUDY; FIBRIN FORMATION; FIBRINOLYSIS; HEMOSTASIS; HEPATITIS; LIVER ISCHEMIA; LIVER NECROSIS; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; REPERFUSION INJURY; THROMBIN TIME;

EID: 77954367978     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00579.x     Document Type: Article

References (42)

1. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 2000, 135:302-8.
2. Blamey SL, Fearon KC, Gilmour WH, Osborne DH, Carter DC. Prediction of risk in biliary surgery. Br J Surg 1983, 70:535-8.
3. Papadopoulos V, Filippou D, Manolis E, Mimidis K. Haemostasis impairment in patients with obstructive jaundice. J Gastrointest Liver Dis 2007, 16:177-86.
4. Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983, 24:845-52.
5. Kloek JJ, Marsman HA, van Vliet AK, Gouma DJ, van Gulik TM. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver. Surgery 2008, 144:22-31.
6. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-35.
7. Golino P, Ragni M, Cirillo P. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996, 2:35-40.
8. Herkert O, Djordjevic T, BelAiba RS, Gorlach A. Insights into the redox control of blood coagulation: role of vascular NADPH oxidase-derived reactive oxygen species in the thrombogenic cycle. Antioxid Redox Signal 2004, 6:765-76.
9. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000, 32:169-73.
10. Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 2002, 277:25032-9.
11. Schoots IG, Levi M, van Vliet AK, Declerck PJ, Maas AM, van Gulik TM. Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion. Thromb Haemost 2004, 91:497-505.
12. Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997, 96:2302-10.
13. Kobayashi Y, Yoshimura N, Nakamura K, Yamagishi H, Oka T. Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat. Transplantation 1998, 66:708-16.
14. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260:62.
15. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000, 46:725-31.
16. Vendemiale G, Grattagliano I, Lupo L, Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol 2002, 37:601-5.
17. Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N. Impaired fibrinolysis in obstructive jaundice - evidence from clinical and experimental studies. Thromb Haemost 1988, 60:25-9.
18. Murray JM, Rowlands BJ, Trinick TR. Indocyanine green clearance and hepatic function during and after prolonged anaesthesia: comparison of halothane with isoflurane. Br J Anaesth 1992, 68:168-71.
19. Ohtsuka M, Miyazaki M, Kondo Y, Nakajima N. Neutrophil-mediated sinusoidal endothelial cell injury after extensive hepatectomy in cholestatic rats. Hepatology 1997, 25:636-41.
20. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-50.
21. Weijer S, Schoenmakers SH, Florquin S. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 2004, 189:2308-17.
22. Levenson RM, Mansfield JR. Multispectral imaging in biology and medicine: slices of life. Cytometry A 2006, 69:748-58.
23. Ten CH, Lamping RJ, Henny CP, Prins A, ten Cate JW. Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity. Clin Chem 1984, 30:860-4.
24. Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982, 48:266-9.
25. Levi M, de Boer JP, Roem D, ten Cate JW, Hack CE. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost 1992, 67:111-16.
26. Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006, 32:33-9.
27. Georgiev P, Navarini AA, Eloranta JJ. Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. Gut 2007, 56:121-8.
28. Wang H, Vohra BP, Zhang Y, Heuckeroth RO. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology 2005, 42:1099-108.
29. Rodzynek JJ, Urbain D, Leautaud P, Wettendorff P, Delcourt A. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance. Gut 1984, 25:1050-6.
30. Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotoxemia, disturbance of coagulation, and obstructive jaundice. Am J Surg 1982, 144:325-9.
31. Okajima K, Harada N, Kushimoto S, Uchiba M. Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost 2002, 88:473-80.
32. Maksan SM, Maksan MO, Gebhard MM, Herfarth C, Klar E. Reduction of hepatic reperfusion injury by antithrombin III and aprotinin. Transpl Int 2000, 13(1):S562-4. Suppl
33. Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999, 93:157-64.
34. Arai M, Mochida S, Ohno A, Fujiwara K. Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation 1996, 62:1398-401.
35. Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 2001, 29:134-9.
36. Nawroth Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986, 163:740-5.
37. Kobayashi M, Shimada K, Ozawa T. Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells. J Cell Physiol 1990, 144:383-90.
38. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989, 73:159-65.
39. Zhang ZG, Chopp M, Goussev A. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J Neurosci 1999, 19:10898-907.
40. Nagai N, Suzuki Y, Van HB, Lijnen HR, Collen D. Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice. J Thromb Haemost 2005, 3:1379-84.
41. Hennerici MG, Kay R, Bogousslavsky J, Lenzi GL, Verstraete M, Orgogozo JM. Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial. Lancet 2006, 368:1871-8.
42. Kim SM, Park KC, Kim HG, Han SJ. Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts. Hepatol Res 2008, 38:800-9.